Removal of senescent cells reduces the viral load and attenuates pulmonary and systemic inflammation in SARS-CoV-2-infected, aged hamsters.


Journal

Nature aging
ISSN: 2662-8465
Titre abrégé: Nat Aging
Pays: United States
ID NLM: 101773306

Informations de publication

Date de publication:
07 2023
Historique:
received: 09 08 2022
accepted: 24 05 2023
medline: 21 7 2023
pubmed: 7 7 2023
entrez: 6 7 2023
Statut: ppublish

Résumé

Older age is one of the strongest risk factors for severe COVID-19. In this study, we determined whether age-associated cellular senescence contributes to the severity of experimental COVID-19. Aged golden hamsters accumulate senescent cells in the lungs, and the senolytic drug ABT-263, a BCL-2 inhibitor, depletes these cells at baseline and during SARS-CoV-2 infection. Relative to young hamsters, aged hamsters had a greater viral load during the acute phase of infection and displayed higher levels of sequelae during the post-acute phase. Early treatment with ABT-263 lowered pulmonary viral load in aged (but not young) animals, an effect associated with lower expression of ACE2, the receptor for SARS-CoV-2. ABT-263 treatment also led to lower pulmonary and systemic levels of senescence-associated secretory phenotype factors and to amelioration of early and late lung disease. These data demonstrate the causative role of age-associated pre-existing senescent cells on COVID-19 severity and have clear clinical relevance.

Identifiants

pubmed: 37414987
doi: 10.1038/s43587-023-00442-w
pii: 10.1038/s43587-023-00442-w
pmc: PMC10353934
doi:

Substances chimiques

navitoclax XKJ5VVK2WD

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

829-845

Informations de copyright

© 2023. The Author(s).

Références

Cell. 2019 Oct 31;179(4):813-827
pubmed: 31675495
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
J Thromb Haemost. 2020 Sep;18(9):2103-2109
pubmed: 32558075
Aging Dis. 2021 Feb 1;12(1):42-49
pubmed: 33532126
J Am Geriatr Soc. 2021 Nov;69(11):3023-3033
pubmed: 34375437
Nat Protoc. 2009;4(12):1798-806
pubmed: 20010931
Cell. 2017 Jun 1;169(6):1000-1011
pubmed: 28575665
Cell Signal. 2020 Jun;70:109588
pubmed: 32109549
Nat Aging. 2022 Feb;2(2):115-124
pubmed: 37117754
EMBO Rep. 2021 Apr 7;22(4):e52243
pubmed: 33734564
Nat Cell Biol. 2021 Dec;23(12):1314-1328
pubmed: 34876692
Front Pharmacol. 2020 Sep 09;11:584637
pubmed: 33013423
EBioMedicine. 2017 Jul;21:21-28
pubmed: 28416161
Cell. 2021 Apr 15;184(8):1990-2019
pubmed: 33811810
BioDrugs. 2008;22(2):85-100
pubmed: 18345706
Nature. 2021 Nov;599(7884):283-289
pubmed: 34517409
Nature. 2011 Nov 02;479(7372):232-6
pubmed: 22048312
Am J Physiol Lung Cell Mol Physiol. 2019 May 1;316(5):L826-L842
pubmed: 30785345
Nat Med. 2017 Sep;23(9):1072-1079
pubmed: 28825716
Sci Rep. 2016 Nov 16;6:37007
pubmed: 27849057
Eur Respir J. 2020 Dec 24;56(6):
pubmed: 33033152
Eur J Pharmacol. 2022 Jan 5;914:174615
pubmed: 34863994
J Virol. 2021 Aug 10;95(17):e0079421
pubmed: 34160250
Int J Gen Med. 2021 Jun 24;14:2807-2816
pubmed: 34194240
Sci Transl Med. 2022 Sep 28;14(664):eabq3059
pubmed: 35857629
Cell Death Dis. 2023 Feb 1;14(2):75
pubmed: 36725844
EBioMedicine. 2019 Sep;47:446-456
pubmed: 31542391
Nature. 2021 Feb;590(7844):140-145
pubmed: 33137809
Clin Exp Immunol. 2017 Jan;187(1):16-25
pubmed: 27711979
Cell. 2008 Aug 22;134(4):657-67
pubmed: 18724938
Int J Gen Med. 2021 Jun 08;14:2359-2366
pubmed: 34135619
Cell Host Microbe. 2020 Jul 8;28(1):124-133.e4
pubmed: 32485164
Science. 2021 Jul 16;373(6552):
pubmed: 34103349
Am J Respir Crit Care Med. 2019 Sep 1;200(5):556-564
pubmed: 30860857
EBioMedicine. 2019 Feb;40:554-563
pubmed: 30616998
J Clin Invest. 2022 Jun 15;132(12):
pubmed: 35536645
Nat Aging. 2021 Sep;1(9):769-782
pubmed: 34746804
iScience. 2021 Dec 17;24(12):103530
pubmed: 34870132
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Aging (Albany NY). 2020 Mar 30;12(8):6511-6517
pubmed: 32229706
Nat Rev Drug Discov. 2017 Oct;16(10):718-735
pubmed: 28729727
Transl Res. 2022 Mar;241:96-108
pubmed: 34695606
Nat Med. 2016 Jan;22(1):78-83
pubmed: 26657143
Cell Rep. 2022 Jun 28;39(13):111002
pubmed: 35714615
Methods Mol Biol. 2020;2099:205-220
pubmed: 31883098
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595
pubmed: 32571934
J Clin Invest. 2013 Mar;123(3):966-72
pubmed: 23454759
Immune Netw. 2016 Oct;16(5):286-295
pubmed: 27799874
Oncotarget. 2016 Dec 6;7(49):81099-81109
pubmed: 27768595
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Aging Cell. 2016 Jun;15(3):428-35
pubmed: 26711051
Adv Virus Res. 2011;81:85-164
pubmed: 22094080
Nat Rev Drug Discov. 2022 Jan;21(1):60-78
pubmed: 34535788
Eur Respir J. 2022 Aug 18;60(2):
pubmed: 35086840
J Exp Med. 2022 Dec 5;219(12):
pubmed: 36129445
Nature. 2018 Oct;562(7728):578-582
pubmed: 30232451
Nature. 2020 Oct;586(7830):560-566
pubmed: 32854108
Am J Respir Crit Care Med. 2006 Nov 1;174(9):997-1002
pubmed: 16917114
Nat Commun. 2021 Jan 4;12(1):4
pubmed: 33397975
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
pubmed: 7568133
Biology (Basel). 2020 Dec 09;9(12):
pubmed: 33317104
Gut Microbes. 2022 Jan-Dec;14(1):2018900
pubmed: 34965194
Front Cell Infect Microbiol. 2020 Jul 28;10:375
pubmed: 32850477
Semin Immunol. 2018 Dec;40:101275
pubmed: 31088710
Ageing Res Rev. 2018 May;43:17-25
pubmed: 29427795
EMBO Rep. 2022 Feb 3;23(2):e53658
pubmed: 34854526
Cell Res. 2021 Apr;31(4):415-432
pubmed: 32913304
Dev Cell. 2014 Dec 22;31(6):722-33
pubmed: 25499914
Am J Respir Cell Mol Biol. 2021 Jan;66(1):107-111
pubmed: 34648725
Cell Death Discov. 2020 Apr 17;6:22
pubmed: 32337074
Nat Rev Immunol. 2023 Apr;23(4):251-263
pubmed: 36198912
Int J Mol Sci. 2017 Feb 25;18(3):
pubmed: 28245616
Life Sci Alliance. 2021 Feb 11;4(4):
pubmed: 33574037
Viruses. 2020 Jul 20;12(7):
pubmed: 32698441
Nat Rev Mol Cell Biol. 2021 Feb;22(2):75-95
pubmed: 33328614
Nature. 2016 Feb 11;530(7589):184-9
pubmed: 26840489
Aging Cell. 2020 Oct;19(10):e13237
pubmed: 32955770
Cell Res. 2020 Jul;30(7):574-589
pubmed: 32341413
Nat Rev Mol Cell Biol. 2014 Jul;15(7):482-96
pubmed: 24954210
Connect Tissue Res. 2019 Jan;60(1):50-61
pubmed: 30343604
Int J Med Sci. 2014 Apr 04;11(6):538-44
pubmed: 24782642
Ageing Res Rev. 2022 Jan;73:101494
pubmed: 34688926
Blood. 2020 Jul 23;136(4):489-500
pubmed: 32492712

Auteurs

Lou Delval (L)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Aline Hantute-Ghesquier (A)

Université de Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277, Institut Pasteur de Lille-CANTHER, Lille, France.

Valentin Sencio (V)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Jean Michel Flaman (JM)

Université de Lyon, CNRS, INSERM, U1052-UMR 5286, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Lyon, France.

Cyril Robil (C)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Fabiola Silva Angulo (FS)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Larissa Lipskaia (L)

Université de Paris-Est Créteil, INSERM U955, Institut Mondor de Recherche Biomédicale, Créteil, France.

Ozmen Çobanoğlu (O)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Anne-Sophie Lacoste (AS)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014, Platforms Lille in Biology & Health, Lille, France.

Arnaud Machelart (A)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Adeline Danneels (A)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Mathieu Corbin (M)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Lucie Deruyter (L)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Séverine Heumel (S)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Thierry Idziorek (T)

Université de Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277, Institut Pasteur de Lille-CANTHER, Lille, France.

Karin Séron (K)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Florent Sauve (F)

Université de Lille, INSERM, CHU Lille, U1172-UMR 9017, Lille Neuroscience & Cognition Research Center, Lille, France.

Antonino Bongiovanni (A)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014, Platforms Lille in Biology & Health, Lille, France.

Vincent Prévot (V)

Université de Lille, INSERM, CHU Lille, U1172-UMR 9017, Lille Neuroscience & Cognition Research Center, Lille, France.

Isabelle Wolowczuk (I)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Sandrine Belouzard (S)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Jean-Michel Saliou (JM)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014, Platforms Lille in Biology & Health, Lille, France.

Philippe Gosset (P)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

David Bernard (D)

Université de Lyon, CNRS, INSERM, U1052-UMR 5286, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Lyon, France.

Yves Rouillé (Y)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France.

Serge Adnot (S)

Université de Paris-Est Créteil, INSERM U955, Institut Mondor de Recherche Biomédicale, Créteil, France.

Martine Duterque-Coquillaud (M)

Université de Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277, Institut Pasteur de Lille-CANTHER, Lille, France.

François Trottein (F)

Université de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille, Lille, France. francois.trottein@pasteur-lille.fr.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH